Surgery Financial Statements From 2010 to 2024

SGRY Stock  USD 32.89  0.84  2.49%   
Surgery Partners financial statements provide useful quarterly and yearly information to potential Surgery Partners investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Surgery Partners financial statements helps investors assess Surgery Partners' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Surgery Partners' valuation are summarized below:
Gross Profit
574.9 M
Profit Margin
(0.01)
Market Capitalization
4.1 B
Enterprise Value Revenue
2.606
Revenue
2.7 B
We have found one hundred eleven available fundamental trend indicators for Surgery Partners, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Surgery Partners current market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. At this time, Surgery Partners' Earnings Before Interest Taxes and Depreciation Amortization EBITDA is fairly stable as compared to the past year. Average Equity is likely to rise to about 1.7 B in 2024, whereas Net Income Per Employee is likely to drop (5.6 K) in 2024.

Surgery Partners Revenues

2.37 Billion

Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery main balance sheet or income statement drivers, such as Direct Expenses of 1.9 B, Consolidated Income of 107.9 M or Cost of Revenue of 1.8 B, as well as many exotic indicators such as Interest Coverage of 1.66, Long Term Debt to Equity of 1.51 or Calculated Tax Rate of 23.13. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
This module can also supplement Surgery Partners' financial leverage analysis and stock options assessment as well as various Surgery Partners Technical models . Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Surgery Partners Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Tax Liabilities118.5 M140.7 M89.9 M
Slightly volatile
Tax Assets114.6 M105.2 M101.1 M
Slightly volatile
Trade and Non Trade Receivables437.1 M524.7 M262.2 M
Slightly volatile
Property Plant and Equipment Net1.4 B1.3 B536.5 M
Slightly volatile
Trade and Non Trade Payables188.1 M174.3 M80.9 M
Slightly volatile
Liabilities Non Current3.5 B3.7 B2.3 B
Slightly volatile
Current Liabilities484.3 M567.4 M294.3 M
Slightly volatile
Total Liabilities3.9 B4.3 B2.6 B
Slightly volatile
Investments Non Current236.1 M218.8 M93.5 M
Slightly volatile
Investments Current10.4 M9.8 M12 M
Slightly volatile
Investments236.1 M218.8 M95.2 M
Slightly volatile
Inventory66.5 M82.1 M37.8 M
Slightly volatile
Goodwill and Intangible AssetsB4.8 B2.4 B
Slightly volatile
Shareholders Equity USD2.5 B2.3 B560.9 M
Slightly volatile
Shareholders Equity Attributable to Parent2.5 B2.3 B560.9 M
Slightly volatile
Deferred Revenue67.2 M58 M97.4 M
Slightly volatile
Total Debt USDB3.3 B1.9 B
Slightly volatile
Debt Non Current2.9 B3.3 B1.9 B
Slightly volatile
Debt Current62.8 M72.2 M40.2 M
Slightly volatile
Total DebtB3.3 B1.9 B
Slightly volatile
Cash and Equivalents USD266.6 M325.3 M153.2 M
Slightly volatile
Cash and Equivalents266.6 M325.3 M153.2 M
Slightly volatile
Assets Non Current5.4 B6.6 B3.1 B
Slightly volatile
Current Assets866.6 M1.1 B504.5 M
Slightly volatile
Total Assets6.3 B7.7 B3.6 B
Slightly volatile
Accumulated Other Comprehensive Income94.5 M87.6 M(5.8 M)
Slightly volatile
Accounts Payable147.2 M136.4 M75.8 M
Slightly volatile
Receivables335.2 M410.7 M249.4 M
Slightly volatile
Inventories50.9 M64.3 M35.7 M
Slightly volatile

Surgery Partners Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Income Tax Expense28.9 M26.8 M2.4 M
Pretty Stable
Weighted Shares Diluted85.2 M105.7 M52.9 M
Slightly volatile
Weighted Shares85.1 M105.7 M52.8 M
Slightly volatile
Selling General and Administrative Expense104.3 M117.5 M70.3 M
Slightly volatile
Revenues USD2.4 B2.9 B1.4 B
Slightly volatile
Revenues2.4 B2.9 B1.4 B
Slightly volatile
Preferred Dividends Income Statement Impact9.5 M9.3 M27.1 M
Slightly volatile
Operating Income431.3 M399.7 M182.1 M
Slightly volatile
Operating Expenses236.1 M261.4 M167.3 M
Slightly volatile
Net Income to Non Controlling Interests140 M162.8 M89.1 M
Slightly volatile
Net Income Common Stock USD(53 M)(49.1 M)(71.4 M)
Slightly volatile
Net Income Common Stock(53 M)(49.1 M)(71.4 M)
Slightly volatile
Net Income(53 M)(49.1 M)(61.4 M)
Slightly volatile
Interest Expense224.5 M270.1 M134.7 M
Slightly volatile
Gross Profit551.2 M661.1 M341.7 M
Slightly volatile
Earning Before Interest and Taxes USD252.6 M234.1 M78.3 M
Slightly volatile
Earning Before Interest and Taxes EBIT252.6 M234.1 M78.3 M
Slightly volatile
Cost of Revenue1.8 B2.3 B1.1 B
Slightly volatile
Consolidated Income107.9 M100 M28.2 M
Slightly volatile
Direct Expenses1.9 B1.8 BB
Slightly volatile

Surgery Partners Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Share Based Compensation22.8 M21.2 M8.9 M
Slightly volatile
Net Cash Flow from Operations163.5 M182.6 M112.4 M
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(76 M)(74.1 M)(24.9 M)
Slightly volatile
Net Cash Flow from Financing68 M48.4 M43.9 M
Pretty Stable
Issuance Repayment of Debt Securities (605.5 M)(590 M)(35.5 M)
Slightly volatile
Issuance Purchase of Equity Shares1.1 B986.4 M404.7 M
Slightly volatile
Net Cash Flow Business Acquisitions and Disposals(142.2 M)(131.8 M)(103.1 M)
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(98.8 M)(96.3 M)654.3 K
Pretty Stable
Depreciation Amortization and Accretion136 M172 M74.5 M
Slightly volatile
Capital Expenditure(62.5 M)(60.9 M)(28.1 M)
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Tangible Assets Book Value per Share29.7131.320.1861
Slightly volatile
Sales per Share32.3631.7624.7354
Slightly volatile
Return on Sales0.07570.0920.0602
Pretty Stable
Return on Invested Capital0.05210.04830.0198
Slightly volatile
Return on Equity(0.0496)(0.046)(0.206)
Pretty Stable
Return on Assets(0.0099)(0.0092)(0.0315)
Slightly volatile
Price to Sales Ratio1.071.160.7979
Slightly volatile
Price to Earnings Ratio(43.62)(42.5)197
Slightly volatile
Price to Book Value1.551.44(90.9632)
Slightly volatile
Profit Margin(0.0273)(0.0253)(0.0536)
Very volatile
Gross Margin0.220.20.2889
Slightly volatile
Free Cash Flow per Share1.631.141.7078
Pretty Stable
Enterprise Value over EBITDA20.5219.02(59.1325)
Slightly volatile
Enterprise Value over EBIT35.9833.35(13.9111)
Slightly volatile
Earnings per Basic Share USD(0.57)(0.53)(1.4089)
Pretty Stable
Earnings per Diluted Share(0.57)(0.53)(1.4089)
Pretty Stable
Earnings per Basic Share(0.57)(0.53)(1.4089)
Pretty Stable
EBITDA Margin0.140.160.1095
Very volatile
Debt to Equity Ratio2.322.15(12.602)
Pretty Stable
Current Ratio1.611.681.7584
Slightly volatile
Book Value per Share26.9624.996.198
Slightly volatile
Asset Turnover0.350.350.3802
Very volatile
Total Assets Per Share62.6261.01250.6 K
Slightly volatile
Cash Flow Per Share1.491.454.7 K
Slightly volatile
Return on Investment9.159.147.5747
Very volatile
Operating Margin16.0715.5713.5551
Very volatile
Calculated Tax Rate23.1321.44(32.1478)
Slightly volatile
Receivables Turnover5.045.165.0651
Slightly volatile
Inventory Turnover26.2826.6925.7562
Slightly volatile
PPandE Turnover4.623.884.3322
Pretty Stable
Cash and Equivalents Turnover11.138.6810.5644
Very volatile
Accounts Payable Turnover22.9321.1218.6881
Slightly volatile
Accrued Expenses Turnover20.4523.4918.2084
Slightly volatile
Interest Coverage1.661.681.3586
Pretty Stable
Long Term Debt to Equity1.511.4769.5938
Slightly volatile
Quick Ratio1.721.711.4524
Pretty Stable
Net Current Assets as percentage of Total Assets7.347.366.6631
Slightly volatile
Revenue to Assets0.450.440.4276
Slightly volatile

Surgery Partners Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Working Capital530.6 M491.7 M220.1 M
Slightly volatile
Tangible Asset Value3.1 B2.9 B1.3 B
Slightly volatile
Market Capitalization2.5 B2.9 B1.5 B
Slightly volatile
Invested Capital Average4.7 B5.6 B2.8 B
Slightly volatile
Invested Capital4.5 B5.3 B2.7 B
Slightly volatile
Free Cash Flow105.5 M104.8 M83.5 M
Slightly volatile
Enterprise Value5.8 B6.7 B3.6 B
Slightly volatile
Average Equity1.7 B1.6 B396.1 M
Slightly volatile
Earnings before Tax(30.4 M)(28.2 M)(59.8 M)
Pretty Stable
Earnings Before Interest Taxes and Depreciation Amortization USD438.2 M406.2 M156 M
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA438.2 M406.2 M156 M
Slightly volatile
Average Assets6.2 B7.4 B3.7 B
Slightly volatile
Revenue Per Employee171.5 K187.3 K148.6 K
Slightly volatile
Net Income Per Employee(5.6 K)(5.1 K)(8.8 K)
Slightly volatile

Surgery Fundamental Market Drivers

Forward Price Earnings20.7469
Cash And Short Term Investments282.9 M

Surgery Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Surgery Partners Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Surgery Partners income statement, its balance sheet, and the statement of cash flows. Surgery Partners investors use historical funamental indicators, such as Surgery Partners's revenue or net income, to determine how well the company is positioned to perform in the future. Although Surgery Partners investors may use each financial statement separately, they are all related. The changes in Surgery Partners's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgery Partners's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Surgery Partners Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Deferred Revenue58 M67.2 M
Cost of Revenue2.3 B1.8 B
Revenues2.9 B2.4 B
Revenue to Assets 0.44  0.45 
Revenue Per Employee187.3 K171.5 K

Currently Active Assets on Macroaxis

When determining whether Surgery Partners offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Surgery Partners' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Surgery Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Surgery Partners Stock:
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Surgery Stock analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Surgery Partners' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgery Partners. If investors know Surgery will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgery Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Revenue Per Share
22.688
Quarterly Revenue Growth
0.086
Return On Assets
0.0372
Return On Equity
0.0388
The market value of Surgery Partners is measured differently than its book value, which is the value of Surgery that is recorded on the company's balance sheet. Investors also form their own opinion of Surgery Partners' value that differs from its market value or its book value, called intrinsic value, which is Surgery Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgery Partners' market value can be influenced by many factors that don't directly affect Surgery Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgery Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgery Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgery Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.